JoeBear - thanks for that thoughtful reply. I knew the info you posted because I usually (unfortunately not always) do my research. I pulled up Missling's LindedIn page and also read about company's past.
I chose to invest in AVXL because: 1. They had a molecule with multiple late stage trials and they had another coming along; 2. They are very careful with maintaining a good balance sheet; and 3. Missling, PhD, MS, MBA has outstanding credentials plus a background in the financial analysis of biotech companies.
I know that in Germany people are very fond of paragraph long titles. I introduced 2 German PhDs at multiple conferences. The first wanted to be introduced as CEO and company cofounder. The 2nd wanted to be introduced as Chief Science Officer and company cofounder. While both were exceptional, the later had received the top industry prize in his field. Neither felt the need to be called doctor.
In the US, I found that many PhDs don't want to be called doctor, except for a small pretentious group who are usually trying to sell something. Are you aware that a lawyer is a "doctor"? Only 1 lawyer I know that calls himself a doctor and that is because he has both MD and JD degrees. Why do so many persist in called Missling a Dr or TGD?
News 
Market Data 
Discover 
AI
